Engage Bio
YC W22Potent, durable, and redosable non-viral genetic medicines
San Francisco, CA, USAFounded 202210 employeesengagebio.com
Team
10
Founded
2022
About
Engage Bio has developed Tethosomes, a new class of non-viral DNA which finally unleashes potent, durable, redosable, and scalable genetic medicine. In 2026 Engage was acquired by Eli Lilly.
Tags
Synthetic Biology Biotech Healthcare Therapeutics Drug discovery Healthcare
No open roles at this time.
Similar Healthcare startups
Alixia
Targeting the Tumor Ecosystem to address cancer drug resistance.
BiotechTherapeuticsDrug discovery
Open Jobs —
Team 2
Founded 2022
Invert
Data analytics software for biomanufacturing.
Cellular AgricultureMachine LearningSynthetic Biology
Open Jobs —
Team 25
Founded 2022
Arintra
Medical coding automation
SaaSHealth TechB2B
Open Jobs —
Team 50
Founded 2022
Mederva
Longevity for the 99%.
Consumer Health ServicesTelehealthDigital Health
Open Jobs —
Team 13
Founded 2022